Influence of ACB complex genospecies on clinical outcomes in a U.S. hospital with high rates of multidrug resistance

Journal of Infection

Volumn 70, Issue 2, 2015, Pages 144-152

  Fitzpatrick, Margaret A ^a   Ozer, Egon ^a   Bolon, Maureen K ^a   Hauser, Alan R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Acinetobacter baumannii; Acinetobacter calcoaceticus; Bacteremia; Genome; Multidrug resistance

Indexed keywords

ACINETOBACTER; ACINETOBACTER INFECTION; ACINETOBACTER NOSOCOMIALIS; ACINETOBACTER PITTII; ADULT; ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIUM ISOLATE; COMORBIDITY; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; RPOB GENE; UNITED STATES; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER INFECTIONS; AGED; DRUG EFFECTS; GENETICS; ILLINOIS; KAPLAN MEIER METHOD; MICROBIOLOGY; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER INFECTIONS; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; ILLINOIS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84921293484     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.09.004     Document Type: Article

References (41)

1. Dijkshoorn L., Nemec A., Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007, 5:939-951.
2. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582.
3. Munoz-Price L.S., Zembower T., Penugonda S., Schreckenberger P., Lavin M.A., Welbel S., et al. Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak. Infect Control Hosp Epidemiol 2010, 31:1057-1062.
4. Falagas M.E., Bliziotis I.A. Siempos, II. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit Care 2006, 10:R48.
5. Sheng W.H., Liao C.H., Lauderdale T.L., Ko W.C., Chen Y.S., Liu J.W., et al. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. Int J Infect Dis 2010, 14:e764-e769.
6. Lee Y.T., Kuo S.C., Yang S.P., Lin Y.T., Tseng F.C., Chen T.L., et al. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection. Clin Infect Dis 2012, 55:209-215.
7. de Gouvea E.F., Martins I.S., Halpern M., Ferreira A.L., Basto S.T., Goncalves R.T., et al. The influence of carbapenem resistance on mortality in solid organ transplant recipients with Acinetobacter baumannii infection. BMC Infect Dis 2012, 12:351.
8. Nemec A., Krizova L., Maixnerova M., van der Reijden T.J., Deschaght P., Passet V., et al. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res Microbiol 2011, 162:393-404.
9. Euzeby J.P. List of Bacterial Names with Standing in Nomenclature: a folder available on the Internet. Int J Syst Bacteriol 1997, 47:590-592.
10. Chiang M.C., Kuo S.C., Chen S.J., Yang S.P., Lee Y.T., Chen T.L., et al. Clinical characteristics and outcomes of bacteremia due to different genomic species of Acinetobacter baumannii complex in patients with solid tumors. Infection 2012, 40:19-26.
11. Chuang Y.C., Sheng W.H., Li S.Y., Lin Y.C., Wang J.T., Chen Y.C., et al. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with Acinetobacter bacteremia. Clin Infect Dis 2011, 52:352-360.
12. Park K.H., Shin J.H., Lee S.Y., Kim S.H., Jang M.O., Kang S.J., et al. The clinical characteristics, carbapenem resistance, and outcome of Acinetobacter bacteremia according to genospecies. PLoS One 2013, 8:e65026.
13. Lee Y.T., Kuo S.C., Yang S.P., Lin Y.T., Chiang D.H., Tseng F.C., et al. Bacteremic nosocomial pneumonia caused by Acinetobacter baumannii and Acinetobacter nosocomialis: a single or two distinct clinical entities?. Clin Microbiol Infect 2013, 19:640-645.
14. Wisplinghoff H., Paulus T., Lugenheim M., Stefanik D., Higgins P.G., Edmond M.B., et al. Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States. J Infect 2012, 64:282-290.
15. Lee Y.C., Huang Y.T., Tan C.K., Kuo Y.W., Liao C.H., Lee P.I., et al. Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes. J Antimicrob Chemother 2011, 66:1839-1846.
16. Lee H.Y., Chen C.L., Wu S.R., Huang C.W., Chiu C.H. Risk factors and outcome analysis of Acinetobacter baumannii complex bacteremia in critical patients. Crit Care Med 2014, 42:1081-1088.
17. Ko W.C., Lee N.Y., Su S.C., Dijkshoorn L., Vaneechoutte M., Wang L.R., et al. Oligonucleotide array-based identification of species in the Acinetobacter calcoaceticus-A. baumannii complex in isolates from blood cultures and antimicrobial susceptibility testing of the isolates. J Clin Microbiol 2008, 46:2052-2059.
18. Ibrahim A., Gerner-Smidt P., Liesack W. Phylogenetic relationship of the twenty-one DNA groups of the genus Acinetobacter as revealed by 16S ribosomal DNA sequence analysis. Int J Syst Bacteriol 1997, 47:837-841.
19. Adams-Haduch J.M., Onuoha E.O., Bogdanovich T., Tian G.B., Marschall J., Urban C.M., et al. Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States. J Clin Microbiol 2011, 49:3849-3854.
20. Saeed S., Fakih M.G., Riederer K., Shah A.R., Khatib R. Interinstitutional and intrainstitutional transmission of a strain of Acinetobacter baumannii detected by molecular analysis: comparison of pulsed-field gel electrophoresis and repetitive sequence-based polymerase chain reaction. Infect Control Hosp Epidemiol 2006, 27:981-983.
21. Turton J.F., Woodford N., Glover J., Yarde S., Kaufmann M.E., Pitt T.L. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 2006, 44:2974-2976.
22. Dijkshoorn L., Aucken H., Gerner-Smidt P., Janssen P., Kaufmann M.E., Garaizar J., et al. Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol 1996, 34:1519-1525.
23. Nemec A., De Baere T., Tjernberg I., Vaneechoutte M., van der Reijden T.J., Dijkshoorn L. Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens. Int J Syst Evol Microbiol 2001, 51:1891-1899.
24. La Scola B., Gundi V.A., Khamis A., Raoult D. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J Clin Microbiol 2006, 44:827-832.
25. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing. Twenty-third informational supplement 2013, CLSI, Wayne, PA.
26. Tian G.B., Adams-Haduch J.M., Bogdanovich T., Pasculle A.W., Quinn J.P., Wang H.N., et al. Identification of diverse OXA-40 group carbapenemases, including a novel variant, OXA-160, from Acinetobacter baumannii in Pennsylvania. Antimicrob Agents Chemother 2011, 55:429-432.
27. Boisvert S., Laviolette F., Corbeil J. Ray: simultaneous assembly of reads from a mix of high-throughput sequencing technologies. J Comput Biol 2010, 17:1519-1533.
28. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997, 25:3389-3402.
29. Camacho C., Coulouris G., Avagyan V., Ma N., Papadopoulos J., Bealer K., et al. BLAST+: architecture and applications. BMC Bioinformatics 2009, 10:421.
30. CDC/NHSN surveillance definitions for specific types of infections 2014, [cited 2014 June 18]. Available from:. http://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf.
31. Horan T.C., Andrus M., Dudeck M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36:309-332.
32. Magiorakos A.P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18:268-281.
33. Wareham D.W., Bean D.C., Khanna P., Hennessy E.M., Krahe D., Ely A., et al. Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance. Eur J Clin Microbiol Infect Dis 2008, 27:607-612.
34. Cisneros J.M., Reyes M.J., Pachon J., Becerril B., Caballero F.J., Garcia-Garmendia J.L., et al. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin Infect Dis 1996, 22:1026-1032.
35. Tseng Y.C., Wang J.T., Wu F.L., Chen Y.C., Chie W.C., Chang S.C. Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii. Diagn Microbiol Infect Dis 2007, 59:181-190.
36. Jang T.N., Lee S.H., Huang C.H., Lee C.L., Chen W.Y. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study. J Hosp Infect 2009, 73:143-150.
37. Lee M.J., Jang S.J., Li X.M., Park G., Kook J.K., Kim M.J., et al. Comparison of rpoB gene sequencing, 16S rRNA gene sequencing, gyrB multiplex PCR, and the VITEK2 system for identification of Acinetobacter clinical isolates. Diagn Microbiol Infect Dis 2014, 78:29-34.
38. Marchaim D., Pogue J.M., Tzuman O., Hayakawa K., Lephart P.R., Salimnia H., et al. Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing method. J Clin Microbiol 2014, 52:1617-1621.
39. Wisplinghoff H., Edmond M.B., Pfaller M.A., Jones R.N., Wenzel R.P., Seifert H. Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility. Clin Infect Dis 2000, 31:690-697.
40. Esterly J.S., Griffith M., Qi C., Malczynski M., Postelnick M.J., Scheetz M.H. Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections. Antimicrob Agents Chemother 2011, 55:4844-4849.
41. Chusri S., Chongsuvivatwong V., Rivera J.I., Silpapojakul K., Singkhamanan K., McNeil E., et al. Clinical Outcomes of Hospital-Acquired Infection with Acinetobacter nosocomialis and Acinetobacter pittii. Antimicrob Agents Chemother 2014, 58:4172-4179.